Precision Optics Competitors

Precision Optics (OTCMKTS:PEYE) and Soleno Therapeutics (NASDAQ:SLNO) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, risk, dividends and analyst recommendations.

Earnings and Valuation

This table compares Precision Optics and Soleno Therapeutics' gross revenue, earnings per share and valuation.

Precision Optics has higher revenue and earnings than Soleno Therapeutics.

Analyst Recommendations

This is a summary of current ratings and price targets for Precision Optics and Soleno Therapeutics, as provided by MarketBeat.

Soleno Therapeutics has a consensus price target of $8.6667, suggesting a potential upside of 673.81%. Given Soleno Therapeutics' higher probable upside, analysts plainly believe Soleno Therapeutics is more favorable than Precision Optics.

Profitability

This table compares Precision Optics and Soleno Therapeutics' net margins, return on equity and return on assets.

Risk & Volatility

Precision Optics has a beta of 0.68, meaning that its share price is 32% less volatile than the S&P 500. Comparatively, Soleno Therapeutics has a beta of 0.71, meaning that its share price is 29% less volatile than the S&P 500.

Insider and Institutional Ownership

55.4% of Soleno Therapeutics shares are owned by institutional investors. 24.7% of Precision Optics shares are owned by insiders. Comparatively, 74.9% of Soleno Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Soleno Therapeutics beats Precision Optics on 7 of the 11 factors compared between the two stocks.

Precision Optics (OTCMKTS:PEYE) and electroCore (NASDAQ:ECOR) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, valuation, analyst recommendations, institutional ownership and risk.

Risk and Volatility

Precision Optics has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500. Comparatively, electroCore has a beta of 1.62, suggesting that its stock price is 62% more volatile than the S&P 500.

Valuation and Earnings

This table compares Precision Optics and electroCore's top-line revenue, earnings per share (EPS) and valuation.

Precision Optics has higher revenue and earnings than electroCore.

Institutional and Insider Ownership

5.5% of electroCore shares are held by institutional investors. 24.7% of Precision Optics shares are held by company insiders. Comparatively, 24.9% of electroCore shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Precision Optics and electroCore's net margins, return on equity and return on assets.

Analyst Ratings

This is a breakdown of current ratings and target prices for Precision Optics and electroCore, as provided by MarketBeat.

electroCore has a consensus price target of $3.70, suggesting a potential upside of 102.19%. Given electroCore's higher possible upside, analysts clearly believe electroCore is more favorable than Precision Optics.

Summary

electroCore beats Precision Optics on 7 of the 12 factors compared between the two stocks.

Electromed (NYSEAMERICAN:ELMD) and Precision Optics (OTCMKTS:PEYE) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, earnings, analyst recommendations, risk, profitability, valuation and institutional ownership.

Analyst Recommendations

This is a summary of recent recommendations and price targets for Electromed and Precision Optics, as provided by MarketBeat.com.

Electromed presently has a consensus target price of $18.00, suggesting a potential upside of 79.10%. Given Electromed's higher possible upside, equities research analysts clearly believe Electromed is more favorable than Precision Optics.

Valuation & Earnings

This table compares Electromed and Precision Optics' revenue, earnings per share and valuation.

Electromed has higher revenue and earnings than Precision Optics.

Volatility and Risk

Electromed has a beta of 0.42, suggesting that its stock price is 58% less volatile than the S&P 500. Comparatively, Precision Optics has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500.

Profitability

This table compares Electromed and Precision Optics' net margins, return on equity and return on assets.

Insider and Institutional Ownership

37.5% of Electromed shares are held by institutional investors. 19.6% of Electromed shares are held by insiders. Comparatively, 24.7% of Precision Optics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Electromed beats Precision Optics on 10 of the 12 factors compared between the two stocks.

Helius Medical Technologies (NASDAQ:HSDT) and Precision Optics (OTCMKTS:PEYE) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk.

Analyst Recommendations

This is a breakdown of recent recommendations for Helius Medical Technologies and Precision Optics, as reported by MarketBeat.

Helius Medical Technologies currently has a consensus target price of $20.00, indicating a potential upside of 15.74%. Given Helius Medical Technologies' higher possible upside, equities research analysts plainly believe Helius Medical Technologies is more favorable than Precision Optics.

Profitability

This table compares Helius Medical Technologies and Precision Optics' net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Helius Medical Technologies and Precision Optics' top-line revenue, earnings per share and valuation.

Precision Optics has higher revenue and earnings than Helius Medical Technologies.

Risk & Volatility

Helius Medical Technologies has a beta of 0.72, indicating that its stock price is 28% less volatile than the S&P 500. Comparatively, Precision Optics has a beta of 0.68, indicating that its stock price is 32% less volatile than the S&P 500.

Fc Global Realty (OTCMKTS:FCRE) and Precision Optics (OTCMKTS:PEYE) are both small-cap computer and technology companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, analyst recommendations, earnings, profitability and dividends.

Profitability

This table compares Fc Global Realty and Precision Optics' net margins, return on equity and return on assets.

Volatility and Risk

Fc Global Realty has a beta of 2.31, suggesting that its stock price is 131% more volatile than the S&P 500. Comparatively, Precision Optics has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and price targets for Fc Global Realty and Precision Optics, as provided by MarketBeat.

Valuation & Earnings

This table compares Fc Global Realty and Precision Optics' top-line revenue, earnings per share and valuation.

Precision Optics has higher revenue and earnings than Fc Global Realty.

Summary

Fc Global Realty beats Precision Optics on 4 of the 7 factors compared between the two stocks.

Precision Optics (OTCMKTS:PEYE) and CHF Solutions (NASDAQ:CHFS) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability and institutional ownership.

Profitability

This table compares Precision Optics and CHF Solutions' net margins, return on equity and return on assets.

Insider & Institutional Ownership

65.1% of CHF Solutions shares are owned by institutional investors. 24.7% of Precision Optics shares are owned by insiders. Comparatively, 0.6% of CHF Solutions shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Valuation and Earnings

This table compares Precision Optics and CHF Solutions' revenue, earnings per share and valuation.

Precision Optics has higher revenue and earnings than CHF Solutions.

Analyst Ratings

This is a summary of recent ratings and target prices for Precision Optics and CHF Solutions, as reported by MarketBeat.

CHF Solutions has a consensus target price of $20.00, indicating a potential upside of 273.83%. Given CHF Solutions' higher possible upside, analysts plainly believe CHF Solutions is more favorable than Precision Optics.

Volatility and Risk

Precision Optics has a beta of 0.68, suggesting that its share price is 32% less volatile than the S&P 500. Comparatively, CHF Solutions has a beta of 1.55, suggesting that its share price is 55% more volatile than the S&P 500.